Adherence to Treatment Regimens Among End-Stage Renal Disease Patients: A Cross-Sectional Study [0.03%]
终末期肾病患者治疗依从性的横断面研究
Fatima Sameer Belhmer,Mohammed Abdullah Al Amad,Mogahed H Albitahi et al.
Fatima Sameer Belhmer et al.
Purpose: Adherence to treatment regimens is crucial to enhance the clinical outcomes of patients with End-Stage Renal Disease (ESRD). In Yemen, there is a gap in information about this issue. Hence, this study aimed to as...
Growth Differentiation Factor-15 as a Potential Biomarker for Renal Involvement in POEMS Syndrome [0.03%]
POEMS综合征肾损害潜在生物标志物 Growth Differentiation Factor-15的研究
Yuan Huang,Jia Chen,Yanlan Yao et al.
Yuan Huang et al.
Introduction: Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a rare plasma cell dyscrasia. Growth differentiation factor-15 (GDF-15) is related with renal functio...
Association Between Lower Serum Mitsugumin 53 Levels and the Risk of Vascular Calcification in Hemodialysis Patients [0.03%]
血清MG53水平降低与维持性血液透析患者血管钙化风险之间的关联
Wenwen Ren,Conghui Liu,Ying Yan et al.
Wenwen Ren et al.
Background: Mitsugumin 53 (MG53) plays a protective role against kidney diseases and cardiovascular diseases, but its mechanism of action is unclear. We speculate that the prevention of cardiovascular disease by MG53 may ...
Predictive Value of Complete Blood Count Indicators for Short-Term Mortality in Patients with Combined Coronary Artery Disease and Chronic Kidney Disease [0.03%]
血液指标预测冠心病合并慢性肾脏疾病患者短期死亡风险的价值
Shuoyan An,Wuqiang Che,Yanxiang Gao et al.
Shuoyan An et al.
Objective: Patients with chronic kidney disease (CKD) and coronary artery disease (CAD) had a poor prognosis. Indicators derived from complete blood count (CBC), like neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte...
Erratum: MicroRNA-203 Expression as Potential Biomarker for Lupus Nephritis [Corrigendum] [0.03%]
微小核糖核酸-203表达作为狼疮性肾炎潜在生物标志物的错误说明[更正]
[This corrects the article DOI: 10.2147/IJNRD.S485409.]. © 2025 Setyawan et al.
Time-Weighted Average Proteinuria and Renal Function Decline in IgA Nephropathy: A Retrospective Cohort Study [0.03%]
免疫球蛋白A肾病患者的时间加权平均尿蛋白与肾功能下降：一项回顾性队列研究
Ricong Xu,Tao Cao,Ying Liao et al.
Ricong Xu et al.
Background: IgA nephropathy (IgAN) is the leading primary glomerulonephritis globally, with many patients advancing to end-stage renal disease. Proteinuria is a key predictor of renal function decline in IgAN, yet the bes...
One-year Survival of End-Stage Kidney Disease Patients Undergoing Hemodialysis in Indonesia [0.03%]
在印度尼西亚进行血液透析的终末期肾病患者的一年生存率研究
Rizky Andhika,Afiatin,Rudi Supriyadi et al.
Rizky Andhika et al.
Background: Chronic Kidney Disease (CKD) represents a significant global health challenge, with Indonesia experiencing the highest surge in End-Stage Kidney Disease (ESKD) prevalence over the past decade. Kidney registrie...
Causal Relationship Between Intelligence, Noncognitive Education, Cognition and Urinary Tract or Kidney Infection: A Mendelian Randomization Study [0.03%]
智力、非认知教育、认知与泌尿系统或肾脏感染之间的因果关系：孟德尔随机化研究
Shuai Fu,Qiang Li,Li Cheng et al.
Shuai Fu et al.
Background: The occurrence of urinary tract or kidney infection is correlated with intelligence, noncognitive education and cognition, but the causal relationship between them remains uncertain, and which risk factors med...
Assessment of Potentially Nephrotoxic Drug Prescriptions in Chronic Kidney Disease Outpatients at a Hospital in Indonesia [0.03%]
印尼一家医院慢性肾脏病门诊潜在肾毒性药物处方的评估
Larasati Arrum Kusumawardani,Hindun Wilda Risni,Darisa Naurahhanan et al.
Larasati Arrum Kusumawardani et al.
Background: Nephrotoxic drugs can worsen the kidney function of patients with chronic kidney disease (CKD). There is still a limited amount of research investigating nephrotoxic drugs in Indonesia. This study aims to anal...
MicroRNA-203 Expression as Potential Biomarker for Lupus Nephritis [0.03%]
微小核糖核酸-203表达量作为狼疮性肾炎潜在生物标志物的作用
Yuswanto Setyawan,Hani Susianti,Hermin Sulistyarti et al.
Yuswanto Setyawan et al.
Introduction and purpose: Lupus nephritis (LN) is the main cause of morbidity and mortality in systemic lupus erythematosus (SLE) patients, therefore the discovery of new biomarkers, which are reliable for the diagnosis o...